SunLink Health Systems Inc (A:SSY)

Feb 13, 2024 06:12 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for its second fiscal quarter ended December 31, 2023 compared to earnings from continuing operations of $2,277,000 (or $0.32 per fully diluted share) for the second fiscal quarter ended December 31, 2022.
Jan 29, 2024 09:26 am ET
Sunlink Health Systems’ Subsidiary Reaches Revised Agreements for the Sale of Trace Regional Medical Center and Clinics
SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its indirect subsidiary, Southern Health Corporation of Houston, Inc. (“Southern”), has reached a revised agreement for the sale of Trace Regional Hospital and three (3) patient clinics in Chickasaw County, MS, (“Trace”) to Progressive Health of Houston, LLC (“Progressive”). Southern sold certain personal and intangible property to Progressive for $500,000 pursuant to an asset purchase agreement, entered into a six-month net lease of certain hospital real property for $20,000 per month, and engaged Progressive under a mana
Dec 12, 2023 09:17 am ET
SunLink Health Systems, Inc. and Progressive Health Group, LLC, Agree to Extend the Closing Date of Their Previously-Announced Sale of Trace Regional Medical Center
SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) today announced that SunLink and Progressive Health Group, LLC (“Progressive”) have amended their previously-announced agreement for the sale by SunLink’s subsidiary, Crown Healthcare Investments, LLC, of Trace Regional Medical Center in Houston, Mississippi, to Progressive to, among other things, extend the closing date until January 31, 2024, on substantially the same price and terms previously announced.
Nov 20, 2023 09:14 am ET
SunLink Health Systems, Inc. Announces Fiscal 2024 First Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2023 compared to a loss from continuing operations of $605,000 (or a loss of $0.09 per fully diluted share) for the first fiscal quarter ended September 30, 2022. On November 10, 2023, the Company's subsidiary, Crown Healthcare Investments, LLC, signed an agreement with Progressive Health Group, LLC, ("Buyer") for the sale of the subsidiary that owns and operates Trace Regional Medical Cente
Nov 13, 2023 05:42 pm ET
SunLink Health Systems Reaches Agreement for Sale of Trace Regional Medical Center
SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its subsidiary, Crown Healthcare Investments, LLC, has signed an agreement with Progressive Health Group, LLC (“Buyer”) for the sale of the subsidiary that owns and operates Trace Regional Medical Center, which includes a hospital, skilled nursing facility and three (3) patient clinics in Chickasaw County, MS, for approximately $8,000,000. The sale is subject to, among other things, the Buyer’s satisfactory completion of its due diligence investigation and a number of customary closing conditions. The company expects to re
Sep 28, 2023 04:02 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2023 Fourth Quarter and Annual Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,436,000 (or a loss of $0.20 per fully diluted share) for its fourth fiscal quarter ended June 30, 2023 compared to a loss from continuing operations of $2,317,000 (or a loss of $0.33 per fully diluted share) for the fourth fiscal quarter ended June 30, 2022. Net loss for the quarter ended June 30, 2023 was $1,426,000 (or a loss of $0.20 per fully diluted share) compared to a net loss of $2,365,000 (or a loss of $0.34 per fully diluted share) for the quarter ended June 30, 2022. The fiscal
Aug 08, 2023 04:08 pm ET
SunLink Health Systems, Inc. Announces Dividend of Fractional Interests in Series C Redeemable Preferred Shares to Holders of Its Common Shares
SunLink Health Systems, Inc. (NYSE American: SSY) today announced that its Board of Directors (a) declared a dividend of one one-thousandth (1/1,000th) of a share (each a “Series C Fractional Interest”) of the Company’s newly-designated Series C Redeemable Preferred Shares, no par value per share (the “Series C Preferred Shares”), for each outstanding common share of the Company (the “Common Shares”), payable on August 16, 2023 to shareholders of record as of 5:00 p.m. Eastern Time on August 15, 2023 and (b) its intent to call a special meeting of shareholders t
Jul 24, 2023 04:44 pm ET
SunLink Health Systems, Inc. Announces the Election of Mark J. Stockslager as Director to Board of Directors
On July 20, 2023, the board of directors (the “Board”) of SunLink Health Systems, Inc. (NYSE American: SSY) (“SSY,” the “Company,” “we,” “us” or “our”) filled a vacant seat on the Board of Directors by electing Mark J. Stockslager as a director of the Company.
May 10, 2023 04:39 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2023 Third Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $727,000 (or a loss of $0.10 per fully diluted share) for its third fiscal quarter ended March 31, 2023 compared to a loss from continuing operations of $934,000 (or a loss of $0.13 per fully diluted share) for the third fiscal quarter ended March 31, 2022. Net loss for the quarter ended March 31, 2023 was $762,000 (or a loss of $0.11 per fully diluted share) compared to a net loss of $990,000 (or a loss of $0.14 per fully diluted share) for the quarter ended March 31, 2022. The fiscal quarte
Feb 15, 2023 11:53 am ET
SunLink Health Systems, Inc. Announces Fiscal 2023 Second Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $2,052,000 ($0.29 per fully diluted share) for its second fiscal quarter ended December 31, 2022 compared to a loss from continuing operations of $477,000 (or a loss of $0.07 per fully diluted share) for the second fiscal quarter ended December 31, 2021. Net earnings for the quarter ended December 31, 2022 were $1,951,000 ($0.28 per fully diluted share) compared to a net loss of $593,000 (or a loss of $0.09 per fully diluted share) for the quarter ended December 31, 2021.
Nov 15, 2022 09:30 am ET
SunLink Health Systems, Inc. Announces Fiscal 2023 First Quarter and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,544,000 (or a loss of $0.22 per fully diluted share) for its first fiscal quarter ended September 30, 2022 compared to earnings from continuing operations of $2,006,000 (or $0.28 per fully diluted share) for the fourth fiscal quarter ended September 30, 2021. Net loss for the quarter ended September 30, 2022 was a loss of $1,558,000 (or a loss of $0.22 per fully diluted share) compared to net earnings of $1,939,000 (or $0.27 per fully diluted share) for the quarter ended June 30, 2021.
Sep 29, 2022 10:02 am ET
SunLink Health Systems, Inc. Announces Fiscal 2022 Fourth Quarter and Annual Results and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $2,317,000 (or a loss of $0.33 per fully diluted share) for its fourth fiscal quarter ended June 30, 2022 compared to earnings from continuing operations of $4,555,000 (or $0.64 per fully diluted share) for the fourth fiscal quarter ended June 30, 2021. Net loss for the quarter ended June 30, 2022 was $2,365,000 (or a loss of $0.34 per fully diluted share) compared to net earnings of $4,687,000 (or $0.66 per fully diluted share) for the quarter ended June 30, 2021.
May 16, 2022 04:09 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2022 Third Quarter Results and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $934,000 (or a loss of $0.13 per fully diluted share) for its third fiscal quarter ended March 31, 2022 compared to a loss from continuing operations of $473,000 (or a loss of $0.07 per fully diluted share) for the third fiscal quarter ended March 31, 2021.
Feb 14, 2022 04:15 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2022 Second Quarter Results and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $477,000 (or a loss of $0.07 per fully diluted share) for its second fiscal quarter ended December 3, 2021 compared to earnings from continuing operations of $3,146,000 ($0.46 per fully diluted share) for the second fiscal quarter ended December 31, 2020.
Nov 15, 2021 09:12 am ET
SunLink Health Systems, Inc. Announces Fiscal 2022 First Quarter Results and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $2,006,000 ($0.28 per fully diluted share) for its first fiscal quarter ended September 30, 2021 compared to a loss from continuing operations of $291,000 (or a loss of $0.04 per fully diluted share) for the first fiscal quarter ended September 30, 2020. Net income for the quarter ended September 30, 2021 was $1,939,000 ($0.27 per fully diluted share) compared to a net loss of $340,000 (or a loss of $0.05 per fully diluted share) for the quarter ended September 30, 2020. The Company’s earni
Sep 28, 2021 10:25 am ET
SunLink Health Systems, Inc. Announces Fiscal 2021 Fourth Quarter and Annual Results and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $4,555,000 ($0.64 per fully diluted share) for its fourth fiscal quarter ended June 30, 2021 compared to a loss from continuing operations of $600,000 (or a loss of $0.09 per fully diluted share) for the quarter ended June 30, 2020. Net income for the quarter ended June 30, 2021 was $4,687,000 ($0.66 per fully diluted share) compared to a net loss of $679,000 (or a loss of $0.10 per fully diluted share) for the quarter ended June 30, 2020. The Company’s earnings for the quarter resulted fro
Aug 20, 2021 10:45 am ET
Thinking about buying stock in Sonnet BioTherapeutics, Progenity, Hexo Corp, SunLink Health Systems, or Endo International?
NEW YORK, Aug. 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SONN, PROG, HEXO, SSY, and ENDP.
May 14, 2021 09:18 am ET
SunLink Health Systems, Inc. Announces Fiscal 2021 Third Quarter Results and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $473,000 (a loss of $0.07 per fully diluted share) for its third fiscal quarter ended March 31, 2021 compared to a loss from continuing operations of $46,000 (a loss of $0.01 per fully diluted share) for the quarter ended March 31, 2020. Net loss for the quarter ended March 31, 2021 was $531,000 (a loss of $0.08 per fully diluted share) compared to a net loss of $158,000 (a loss of $0.02 per fully diluted share) for the quarter ended March 31, 2020. The Company recognized $11,000 (pre-tax) of
Mar 15, 2021 05:04 pm ET
Sunlink Health Systems, Inc. Announces $2 Million Expansion, Capital and Operating Improvements at Trace Regional Hospital
SunLink Health Systems, Inc. (NYSE American: SSY) announced today that its wholly-owned subsidiary, Trace Regional Hospital, has implemented its Trace Forward Capital Plan totaling approximately $2 million to expand, upgrade and improve its physical plant, patient care, ancillary services and support areas. The Trace Forward Capital Plan includes an 8-bed expansion of its Pathways Care Program, a geriatric behavioral health service, which will bring Pathways to 26 total beds. The Plan also features modernized, acute care patient rooms with renovated support areas, a complete hospital-wide repl
Feb 16, 2021 09:09 am ET
SunLink Health Systems, Inc. Announces Fiscal 2021 Second Quarter Results, Recognition of a Portion of Provider Relief Funds Received, and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $3,146,000 ($0.46 per fully diluted share) for its second fiscal quarter ended December 31, 2020 compared to earnings of $203,000 ($0.03 per fully diluted share) for the quarter ended December 31, 2019. Net earnings for the quarter ended December 31, 2020 were $3,074,000 ($0.45 per fully diluted share) compared to a net loss of $42,000 (a loss of $0.01 per fully diluted share) for the quarter ended December 31, 2019. The current fiscal year’s quarter included pre-tax income of $3,417,000 re
Nov 13, 2020 10:56 am ET
SunLink Health Systems, Inc. Announces Fiscal 2021 First Quarter Results and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $291,000 (a loss of $0.04 per fully diluted share) for its first fiscal quarter ended September 30, 2020 compared to a loss of $143,000, (a loss of $0.02 per fully diluted share) for the quarter ended September 30, 2019. Net loss for the quarter ended September 30, 2020 was $340,000 (a loss of $0.05 per fully diluted share) compared to a net loss of $261,000 ($0.04 per fully diluted share) for the quarter ended September 30, 2019.
Sep 29, 2020 11:12 am ET
SunLink Health Systems, Inc. Announces Fiscal 2020 Fourth Quarter and Annual Results and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $600,000 (a loss of $0.09 per fully diluted share) for its fourth fiscal quarter ended June 30, 2020 compared to a loss of $1,143,000, (a loss of $0.16 per fully diluted share) for the quarter ended June 30, 2019. Net loss for the quarter ended June 30, 2020 was $679,000 (a loss of $0.10 per fully diluted share) compared to a net loss of $2,221,000 ($0.32 per fully diluted share) for the quarter ended June 30, 2019.
Jun 02, 2020 08:51 am ET
SunLink Health Systems, Inc. Announces Termination of Its Previously Suspended Share Repurchase Program
SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its share repurchase program terminated pursuant to its terms on June 1, 2020. The program was previously suspended on March 24, 2020, due to uncertainly relating to the COVID-19 pandemic.
May 14, 2020 04:55 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2020 Third Quarter Results and COVID-19 Update
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $46,000 (a loss of $0.01 per fully diluted share) for its third fiscal quarter ended March 31, 2020 compared to a loss of $325,000, (a loss of $0.05 per fully diluted share) for the quarter ended March 31, 2019. Net loss for the quarter ended March 31, 2020 was $158,000 (a loss of $0.02 per fully diluted share) compared to net earnings of $1,042,000 ($0.15 per fully diluted share) for the quarter ended March 31, 2019. Net earnings for the quarter ended March 31, 2019 includes a pre-tax gain o
Mar 25, 2020 04:31 pm ET
SunLink Health Systems, Inc. Announces Suspension of Share Repurchase Program
SunLink Health Systems, Inc. (NYSE American: SSY) announced today that it is suspending its Share Repurchase Program in light of the COVID-19 pandemic. SunLink’s management believes the suspension, while conservative, is prudent given uncertainty regarding the length and severity of the pandemic and potential uncertainty regarding the impact of the pandemic on the timeliness of reimbursement claims and payments under various Federal and state programs (e.g., Medicare and Medicaid) and from private payors. SunLink has the ability to reinstate repurchases as circumstances warrant subject to comp
Mar 20, 2020 09:31 am ET
Thinking about buying stock in EXACT Sciences, GenMark Diagnostics, SunLink Health Systems, Tyson Foods, or Slack Technologies?
NEW YORK, March 20, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EXAS, GNMK, SSY, TSN, and WORK.
Feb 13, 2020 04:24 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2020 Second Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $203,000 ($0.03 per fully diluted share) for its second fiscal quarter ended December 31, 2019 compared to earnings of $258,000, ($0.04 per fully diluted share) for the quarter ended December 31, 2018. Net loss for the quarter ended December 31, 2019 was $42,000 (or a loss of $0.01 per fully diluted share) compared to net earnings of $305,000 ($0.04 per fully diluted share) for the quarter ended December 31, 2018.
Jan 31, 2020 09:26 am ET
SunLink Health Systems, Inc. Announces Extension of Share Repurchase Program to Repurchase up to $750,000 of Its Common Shares Through Open Market Transactions at Prevailing Market Prices
SunLink Health Systems, Inc. (NYSE American: SSY) today announced that it has extended its previously announced Share Repurchase Program to repurchase for cash up to $750,000 of its common shares through open market transactions at prevailing market prices (the “Program”) upon the terms and subject to the conditions described in its Schedule 13E-3, as amended, including in the Notice of Share Repurchase Program, as amended (the “Notice”), until 4:00 p.m., New York City time, on Monday, June 1, 2020 (the “Expiration Time”), unless the Program is further extended or earlier terminated by SunLink
Nov 14, 2019 09:03 am ET
SunLink Health Systems, Inc. Announces Fiscal 2020 First Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $143,000 (a loss of $0.02 per fully diluted share) for its first fiscal quarter ended September 30, 2019 compared to a loss of $786,000, (a loss of $0.11 per fully diluted share) for the quarter ended September 30, 2018. Net loss for the quarter ended September 30, 2019 was $261,000 (a loss of $0.04 per fully diluted share) compared to a net loss of $880,000 ( a loss of $0.12 per fully diluted share) for the quarter ended September 30, 2018. During the quarter ended September 30, 2019, SunLin
Oct 17, 2019 09:09 am ET
SunLink Health Systems, Inc Announces Form 13e-3 Filing and Notice to Shareholders in Connection With It’s Share Repurchase Plan
SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that it has filed with the Securities and Exchange Commission a Form 13e-3 relating to the share repurchase plan approved by its Board. The share repurchase program authorizes the Company to expend up to $750,000 to purchase shares of its common stock in the open market. A notice is currently being mailed to all shareholders describing the plan, and the company will commence purchases, at its discretion, under the plan no sooner than November 14, 2019, 30 days after the mailing of the notice.
Oct 08, 2019 08:38 am ET
SunLink Health Systems, Inc Announces Share Repurchase Plan and Debt Paydown
SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that its Board of Directors had approved a share repurchase program that authorizes the Company to expend up to $750,000 to purchase shares of its common stock in the open market. In addition, the Board approved a $2,500,000 pre-payment of mortgage debt on its subsidiary which operates Trace Regional Hospital and Floy Dyer Nursing Home.
Sep 27, 2019 08:38 am ET
SunLink Health Systems, Inc. Announces Fiscal 2019 Fourth Quarter and Annual Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,143,000 (a loss of $0.16 per fully diluted share) for its fourth fiscal quarter ended June 30, 2019 compared to a loss of $609,000, (a loss of $0.08 per fully diluted share) for the quarter ended June 30, 2018. Net loss for the quarter ended June 30, 2019 was a loss of $2,221,000 (a loss of $0.32 per fully diluted share) compared to a net loss of $1,454,000 ( loss of $0.20 per fully diluted share) for the quarter ended June 30, 2018.
May 14, 2019 04:35 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2019 Third Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced net earnings of $1,042,000 ($0.15 per fully diluted share) for its third fiscal quarter ended March 31, 2019 compared to a net loss of $588,000 (a loss of $0.08 per fully diluted share) for the quarter ended March 31, 2018. The net earnings in the current year’s quarter are due to the $2,136,000 pre-tax gain on the previously announced sale of a subsidiary’s nursing home and related property. The Company had a loss from continuing operations for its fiscal quarter ended March 31,
Mar 19, 2019 09:22 am ET
SunLink Health Systems, Inc. Completes Sale of Parkside Ellijay Nursing Home and Real Estate
SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Ellijay, Inc., has completed the sale of its Parkside Ellijay Nursing Home and related real estate for approximately $7,300,000. The company said the net proceeds of approximately $6,400,000 will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax gain on the sale of approximately $2,100,000 in its third fiscal quarter ending March 31, 2019.
Mar 01, 2019 09:13 am ET
SunLink Health Systems, Inc. Announces Agreement for Sale of Parkside Ellijay Nursing Home and Real Estate
SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Ellijay, Inc., has signed a definitive agreement for the sale of its Parkside Ellijay Nursing Home and related real estate for approximately $7,300,000. The sale is scheduled to close on or about March 15, 2019, subject to certain closing conditions. The company said the net proceeds of approximately $6,600,000 will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax gain on
Feb 13, 2019 06:05 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2019 Second Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $354,000 ($0.05 per fully diluted share) for its second fiscal quarter ended December 31, 2018 compared to earnings of $799,000, ($0.09 per fully diluted share) for the quarter ended December 31, 2017. Net earnings for the quarter ended December 31, 2018 were $305,000 (a $0.04 per fully diluted share) compared to net earnings of $726,000 ($0.08 per fully diluted share) for the quarter ended December 31, 2017. Included in the net earnings for
Dec 13, 2018 09:20 am ET
SunLink Health Systems, Inc. Announces Amendment to Its Share Repurchase Program
SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that, having purchased all the 300,000 shares authorized under its share repurchase program announced November 29, 2018, its Board of Directors has approved a modification to the share repurchase program that authorizes the Company to purchase up to an additional 450,000 shares of its common stock or approximately 6% of its currently outstanding shares.
Nov 29, 2018 08:37 am ET
SunLink Health Systems, Inc. Announces Share Repurchase Plan
SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that its Board of Directors had approved a share repurchase program that authorizes the Company to purchase up to 300,000 shares of its common stock or approximately 4% of its currently outstanding shares.
Nov 26, 2018 08:50 am ET
Consolidated Research: 2018 Summary Expectations for Ur Energy, SilverCrest Metals, Norwegian Cruise Line, Inovio Pharmaceuticals, Spok, and SunLink Health — Fundamental Analysis, Key Performance Indi
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Ur Energy Inc (NYSE:URG), SilverCrest Metals Inc. (NYSE:SILV),...
Nov 14, 2018 04:10 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2019 First Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $817,000 (a loss of $0.11 per fully diluted share) for its first fiscal quarter ended September 30, 2018 compared to a loss of $224,000, (a loss of $0.02 per fully diluted share) for the quarter ended September 30, 2017. Net loss for the quarter ended September 30, 2018 was a loss of $880,000 (a loss of $0.12 per fully diluted share) compared to a net loss of $277,000 (a loss of $0.03 per fully diluted share) for the quarter ended September 30,
Oct 11, 2018 04:31 pm ET
SunLink Health Systems, Inc. Announces Sale of Medical Office Building and Land
SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced the sale of a medical office building and approximately two adjacent acres of undeveloped land in Dahlonega, GA. After expenses, the company expects net proceeds from the sale of approximately $935,000, which will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax gain on the sale of approximately $452,000.
Sep 25, 2018 05:13 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2018 Fourth Quarter and Annual Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,104,000 (a loss of $0.15 per fully diluted share) for its fourth fiscal quarter ended June 30, 2018 compared to a loss of $2,768,000, (a loss of $0.30 per fully diluted share) for the quarter ended June 30, 2017. Net loss for the quarter ended June 30, 2018 was a loss of $1,454,000 (a loss of $0.20 per fully diluted share) compared to a net loss of $2,408,000 ( loss of $0.26 per fully diluted share) for the quarter ended June 30, 2017.
May 11, 2018 09:20 am ET
SunLink Health Systems, Inc. Announces Fiscal 2018 Third Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a Loss from Continuing Operations of $604,000, or a loss of $0.08 per fully diluted share, for its third fiscal quarter ended March 31, 2018 compared to a Loss from Continuing Operations of $890,000, or a loss of $0.10 per fully diluted share, for the quarter ended March 31, 2017. The Net Loss for the quarter ended March 31, 2018 was $588,000, or a loss of $0.08 per fully diluted share compared to a Net Loss of $1,025,000, or a loss of $0.11 per fully diluted share, for the quarte
Feb 14, 2018 04:10 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2018 Second Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $799,000, or $0.09 per fully diluted share, for its second fiscal quarter ended December 31, 2017 compared to earnings of $2,949,000, or $0.31 per fully diluted share, for the quarter ended December 31, 2016. Included in the earnings for the second quarter ended December 31, 2017 were:
Dec 29, 2017 09:06 am ET
SunLink Health Systems, Inc. and Southern Health Corporation of Houston, Inc. Announce Pay-Down and Modification of RDA Loan
SunLink Health Systems, Inc. (NYSE American: SSY) (“The Company”) and its wholly-owned subsidiary, Southern Health Corporation of Houston, Inc. (“Trace”), today completed their previously-announced modification and pay-down of Trace’s Department of Agriculture Rural Development Loan ("RDA Loan"). Under the modification, Trace has made a $3,548,000 prepayment on the RDA Loan which will reduce the principal balance to approximately $3,500,000 at December 31, 2017. The lender has reduced the monthly principal payments on the RDA Loan to $39,050 per
Dec 28, 2017 09:12 am ET
SunLink Health Systems, Inc. Announces Final Results of Tender Offer
SunLink Health Systems, Inc. (NYSE American: SSY) today announced the final results of its tender offer (the “Offer”) which expired at midnight, New York City Time, on December 21, 2017. In the Offer, SunLink offered to purchase up to $2,500,000 of its common shares at a price of $1.60 per share.
Dec 22, 2017 09:11 am ET
SunLink Health Systems, Inc. Announces Preliminary Results for Tender Offer
SunLink Health Systems, Inc. (NYSE American: SSY) announced today the preliminary results of its tender offer (the “Offer”) which expired at midnight, New York City Time, on December 21, 2017. In the Offer, SunLink offered to purchase up to $2,500,000 of its common shares at a price of $1.60 per share.
Nov 21, 2017 05:22 pm ET
SunLink Health Systems, Inc. Announces Commencement of Tender Offer to Repurchase up to 1,562,500 of Its Common Shares at a Price of $1.60 Per Share
SunLink Health Systems, Inc. (NYSE American: SSY) announced today that it has commenced a tender offer to purchase up to 1,562,500 of its common shares at a price of $1.60 per share (the “Offer”). The number of shares proposed to be purchased in the Offer represents approximately 17.05% of the approximately 9,162,565 of SunLink’s outstanding common shares as of November 20, 2017 and involves an aggregate purchase price of $2,500,000. On November 20, 2017, the last full trading day prior to the announcement of the Offer, the reported closing pric
Nov 21, 2017 08:30 am ET
SunLink Health Systems, Inc. Announces Intention to Commence Tender Offer to Repurchase up to 1,562,500 of Its Common Shares
SunLink Health Systems, Inc. (NYSE American: SSY) announced today that it intends to commence a cash tender offer within the next week to purchase up to 1,562,500 of its common shares at a price of $1.60 per share. The number of shares proposed to be purchased in the tender offer represents approximately 17.05% of SunLink’s currently outstanding common shares and involves an aggregate purchase price of $2,500,000. The NYSE closing price of SunLink’s common shares on November 20, 2017 was $1.49 per share.
Nov 14, 2017 04:27 pm ET
SunLink Health Systems, Inc. Announces Fiscal 2018 First Quarter Results
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $224,000 or a loss of $0.02 per fully diluted share for its first fiscal quarter ended September 30, 2017 compared to a loss of $1,250,000, or a loss of $0.13 per fully diluted share, for the quarter ended September 30, 2016. Net loss for the quarter ended September 30, 2017 was a loss of $277,000 or a loss of $0.03 per fully diluted share compared to net earnings of $3,023,000 or $0.32 per fully diluted share, for the quarter ended September 3

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.

Learn More